Is modulation of multidrug resistance a viable strategy for acute myeloid leukemia?
Larson
R A
RA
Department of Medicine and Cancer Research Center, Section of Hematology/Oncology, The University of Chicago, IL 60637, USA.
D000208:Acute Disease; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D018432:Drug Resistance, Multiple; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D012074:Remission Induction / Q000379:methods; D016896:Treatment Outcome
D000970:Antineoplastic Agents